ORIC Pharmaceuticals, Inc. (ORIC)

NASDAQ: ORIC · IEX Real-Time Price · USD

10.22

0.00 (0.00%)

At close: Jul 19, 2024, 4:00 PM

10.08

-0.14 (-1.37%)

Pre-market: Jul 22, 2024, 8:20 AM EDT

ORIC Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Net Income	-101.76	-100.7	-89.12	-78.72	-73.7	-26.88	Upgrade
Depreciation & Amortization	1.04	1.03	0.97	0.9	0.97	1.03	Upgrade
Share-Based Compensation	16.57	15.23	14.46	12.85	5.28	1.09	Upgrade
Other Operating Activities	-11.09	-1.25	-1.45	5.42	22.19	1.23	Upgrade
Operating Cash Flow	-95.25	-85.69	-75.14	-59.54	-45.27	-23.53	Upgrade
Capital Expenditures	-0.76	-0.85	-2.08	-0.94	-0.67	-0.77	Upgrade
Change in Investments	-117.29	-42.55	-107.17	159.37	-215.29	0	Upgrade
Investing Cash Flow	-118.05	-43.4	-109.25	158.44	-215.96	-0.77	Upgrade
Share Issuance / Repurchase	211.08	85.89	25.62	50.99	271.75	0.13	Upgrade
Other Financing Activities	-0.4	-0.23	-0.4	-1.85	-21.24	70.69	Upgrade
Financing Cash Flow	210.69	85.66	25.23	49.13	250.51	70.82	Upgrade
Net Cash Flow	-2.61	-43.43	-159.17	148.03	-10.71	46.52	Upgrade
Free Cash Flow	-96	-86.54	-77.22	-60.48	-45.94	-24.3	Upgrade
Free Cash Flow Per Share	-1.43	-1.68	-1.95	-1.59	-2.09	-12.79	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).